Retinal Blood Flow and Autoregulation
Public ClinicalTrials.gov record NCT05344274. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Direct Measures of Retinal Blood Flow and Autoregulation as Robust Biomarkers for Early Glaucoma
Study identification
- NCT ID
- NCT05344274
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- University of Maryland, Baltimore
- Other
- Enrollment
- 90 participants
Conditions and interventions
Conditions
Interventions
- Indocyanine Green Angiography Diagnostic Test
- Isocapnic Oxygen Biological
- Ocular Imaging with Optical Coherence Tomography (OCT) and Adaptive Optics (AO) Diagnostic Test
Diagnostic Test · Biological
Eligibility (public fields only)
- Age range
- 18 Years to 88 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 22, 2022
- Primary completion
- Aug 31, 2027
- Completion
- Aug 31, 2027
- Last update posted
- Dec 1, 2025
2022 – 2027
United States locations
- U.S. sites
- 4
- U.S. states
- 1
- U.S. cities
- 2
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Maryland Faculty Physicians, Inc | Baltimore | Maryland | 21201 | Recruiting |
| University of Maryland Medical Center | Baltimore | Maryland | 21201 | Recruiting |
| University of Maryland, Baltimore | Baltimore | Maryland | 21201 | Recruiting |
| Food and Drug Administration (FDA) | Silver Spring | Maryland | 20903 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05344274, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 1, 2025 · Synced Jul 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05344274 live on ClinicalTrials.gov.